| BHVN |
Biohaven Ltd. |
1.99b |
12.99 |
(1.52%) |
0.00 |
0.00% |
425.20% |
— |
| LKFT |
Lakefront Biotherapeutics - Sponsored ADR |
1.99b |
29.38 |
(3.23%) |
0.00 |
(6.81%) |
(52.22%) |
— |
| MRVI |
Maravai LifeSciences Holdings, Inc. |
1.99b |
7.60 |
(0.65%) |
0.00 |
(37.07%) |
(5.03%) |
0.26% |
| SRPT |
Sarepta Therapeutics, Inc. |
1.97b |
18.67 |
1.52% |
0.00 |
(6.93%) |
(20.44%) |
— |
| ZYME |
Zymeworks Inc. |
1.92b |
26.52 |
(1.08%) |
0.00 |
(404.00%) |
(69.78%) |
— |
| FTRE |
Fortrea Holdings Inc. |
1.90b |
19.89 |
(0.65%) |
0.00 |
(3.18%) |
(2.09%) |
— |
| VIR |
Vir Biotechnology, Inc. |
1.81b |
10.66 |
(0.28%) |
0.00 |
(83.00%) |
1,495.93% |
— |
| ABSI |
Absci Corporation |
1.81b |
9.74 |
(5.89%) |
0.00 |
(7,756.37%) |
(62.28%) |
— |
| XNCR |
Xencor, Inc. |
1.79b |
23.80 |
(0.34%) |
0.00 |
(155.59%) |
(28.56%) |
— |
| ZBIO |
Zenas BioPharma, Inc. |
1.79b |
26.95 |
(0.98%) |
0.00 |
0.00% |
— |
— |
| SEPN |
Septerna, Inc. |
1.78b |
37.77 |
(0.94%) |
0.00 |
(24.51%) |
13,520.11% |
— |
| NVAX |
Novavax, Inc. |
1.75b |
10.63 |
0.28% |
0.00 |
(59.87%) |
(61.64%) |
— |
| NTLA |
Intellia Therapeutics, Inc. |
1.72b |
11.75 |
(3.37%) |
0.00 |
(672.16%) |
12.58% |
— |
| NBTX |
Nanobiotix S.A. - Sponsored ADR |
1.69b |
33.31 |
(0.45%) |
0.00 |
0.00% |
— |
— |
| KRSA |
Cyclerion Therapeutics, Inc. |
1.69b |
31.00 |
(16.64%) |
0.00 |
0.00% |
30.77% |
— |
| GHRS |
GH Research PLC |
1.68b |
23.84 |
(2.49%) |
0.00 |
0.00% |
— |
— |
| STOK |
Stoke Therapeutics, Inc. |
1.63b |
24.80 |
(1.94%) |
0.00 |
(753.60%) |
(86.20%) |
— |
| IMCR |
Immunocore Holdings PLC Sponsored ADR |
1.61b |
30.72 |
(1.82%) |
0.00 |
(4.20%) |
20.95% |
— |
| SNDX |
Syndax Pharmaceuticals, Inc. |
1.60b |
18.20 |
1.28% |
0.00 |
(87.60%) |
222.34% |
— |
| RAPP |
Rapport Therapeutics, Inc. |
1.58b |
33.91 |
0.24% |
0.00 |
0.00% |
— |
— |
| TSHA |
Taysha Gene Therapies, Inc. |
1.56b |
4.67 |
(2.51%) |
0.00 |
0.00% |
18.96% |
— |
| ANAB |
AnaptysBio, Inc. |
1.55b |
51.00 |
(1.35%) |
0.00 |
(11.53%) |
107.73% |
— |
| TYRA |
Tyra Biosciences, Inc. |
1.54b |
21.76 |
(2.77%) |
0.00 |
0.00% |
— |
— |
| AVBP |
ArriVent BioPharma, Inc. |
1.48b |
28.45 |
(5.48%) |
0.00 |
0.00% |
— |
— |
| MAZE |
Maze Therapeutics, Inc. |
1.48b |
26.05 |
(0.61%) |
0.00 |
0.00% |
— |
— |
| INBX |
Inhibrx Biosciences, Inc. |
1.48b |
99.61 |
(0.79%) |
0.00 |
0.00% |
— |
— |
| OMER |
Omeros Corporation |
1.46b |
20.08 |
(1.04%) |
11.65 |
128.36% |
36.32% |
— |
| RARE |
Ultragenyx Pharmaceutical Inc. |
1.45b |
14.50 |
(1.83%) |
0.00 |
(81.73%) |
17.51% |
— |
| DRTS |
Alpha Tau Medical Ltd. |
1.43b |
14.54 |
(1.08%) |
0.00 |
0.00% |
— |
— |
| AAPG |
Ascentage Pharma Group International - Unsponsored ADR |
1.40b |
14.86 |
(2.43%) |
— |
— |
— |
— |
| ORIC |
Oric Pharmaceuticals, Inc. |
1.37b |
13.16 |
(0.15%) |
0.00 |
0.00% |
— |
— |
| BCAX |
Bicara Therapeutics Inc. |
1.32b |
19.21 |
(2.88%) |
0.00 |
0.00% |
— |
— |
| IMTX |
Immatics N.V. |
1.26b |
8.37 |
0.48% |
0.00 |
(489.35%) |
(64.99%) |
— |
| DMRA |
Galecto, Inc. |
1.25b |
20.66 |
1.92% |
0.00 |
0.00% |
— |
— |
| LBRX |
LB Pharmaceuticals Inc |
1.22b |
37.33 |
(1.24%) |
0.00 |
0.00% |
— |
— |
| REPL |
Replimune Group, Inc. |
1.20b |
12.36 |
(1.59%) |
0.00 |
0.00% |
— |
— |
| AKTS |
Aktis Oncology, Inc. |
1.09b |
19.43 |
0.00% |
0.00 |
(781.95%) |
— |
— |
| VOR |
Vor Biopharma Inc. |
1.09b |
18.52 |
0.43% |
0.00 |
0.00% |
— |
— |
| ANRO |
Alto Neuroscience, Inc. |
1.07b |
26.49 |
(2.54%) |
0.00 |
0.00% |
— |
— |
| MGTX |
MeiraGTx Holdings PLC |
1.06b |
10.91 |
(1.27%) |
14.36 |
19.87% |
948.35% |
— |
| MNKD |
MannKind Corporation |
1.06b |
3.34 |
1.52% |
0.00 |
(11.08%) |
30.46% |
— |
| SVRA |
Savara Inc. |
1.04b |
5.00 |
(1.38%) |
0.00 |
0.00% |
— |
— |
| MLTX |
MoonLake Immunotherapeutics |
1.03b |
12.04 |
(0.66%) |
0.00 |
0.00% |
— |
— |
| JANX |
Janux Therapeutics, Inc. |
1.02b |
16.30 |
(2.28%) |
0.00 |
(427.47%) |
83.92% |
— |
| GLUE |
Monte Rosa Therapeutics, Inc. |
999.87m |
11.77 |
0.43% |
0.00 |
(560.85%) |
(83.86%) |
— |
| CRVS |
Corvus Pharmaceuticals, Inc. |
992.63m |
11.62 |
(1.53%) |
0.00 |
0.00% |
— |
— |
| CGEM |
Cullinan Therapeutics, Inc. |
992.35m |
14.81 |
(4.60%) |
0.00 |
0.00% |
— |
— |
| ALMS |
Alumis Inc. |
985.86m |
7.10 |
(2.61%) |
0.00 |
(5,933.45%) |
— |
— |
| KURA |
Kura Oncology, Inc. |
977.67m |
10.76 |
(0.37%) |
0.00 |
(384.30%) |
— |
— |
| JBIO |
Jade Biosciences, Inc. |
936.79m |
14.42 |
(2.10%) |
0.00 |
0.00% |
— |
— |
| ANL |
Adlai Nortye Ltd. Sponsored ADR |
929.70m |
15.53 |
(1.90%) |
— |
— |
— |
— |
| HELP |
Cybin Inc. |
926.40m |
12.61 |
0.16% |
0.00 |
0.00% |
— |
— |
| SANA |
Sana Biotechnology, Inc. |
904.07m |
2.95 |
(0.34%) |
0.00 |
0.00% |
— |
— |
| RIGL |
Rigel Pharmaceuticals, Inc. |
894.58m |
48.18 |
0.61% |
2.73 |
116.30% |
3.31% |
— |
| CADL |
Candel Therapeutics, Inc. |
883.79m |
11.02 |
(4.59%) |
0.00 |
0.00% |
0.00% |
— |
| ARDX |
Ardelyx, Inc. |
859.70m |
3.42 |
(0.87%) |
0.00 |
(12.35%) |
16.77% |
— |
| LXRX |
Lexicon Pharmaceuticals, Inc. |
854.32m |
1.80 |
(3.23%) |
0.00 |
(147.38%) |
(29.03%) |
— |
| IMMX |
Immix Biopharma, Inc. |
844.32m |
10.97 |
(5.73%) |
0.00 |
0.00% |
— |
— |
| AVTX |
Avalo Therapeutics, Inc. |
843.06m |
15.47 |
(1.59%) |
0.00 |
0.00% |
(92.65%) |
— |
| GERN |
Geron Corporation |
815.94m |
1.26 |
0.00% |
0.00 |
(33.05%) |
24.39% |
— |
| ACHV |
Achieve Life Sciences, Inc. |
813.96m |
7.54 |
(3.96%) |
0.00 |
0.00% |
(5.58%) |
— |
| DSGN |
Design Therapeutics, Inc. |
809.26m |
12.12 |
(1.62%) |
0.00 |
0.00% |
— |
— |
| FDMT |
4D Molecular Therapeutics, Inc. |
807.12m |
14.47 |
(1.63%) |
0.00 |
(194.74%) |
278,712.12% |
— |
| SLDB |
Solid Biosciences Inc. |
802.04m |
7.29 |
(2.54%) |
0.00 |
0.00% |
— |
— |
| OLMA |
Olema Pharmaceuticals, Inc. |
790.98m |
8.75 |
(3.21%) |
0.00 |
0.00% |
— |
— |
| WVE |
WAVE Life Sciences Ltd. |
780.31m |
3.78 |
(4.55%) |
0.00 |
(309.73%) |
(30.42%) |
— |
| GYRE |
Gyre Therapeutics, Inc. |
777.23m |
7.35 |
0.27% |
0.00 |
(13.73%) |
10.72% |
— |
| IVA |
Inventiva S.A. Sponsored ADR |
767.78m |
3.37 |
3.37% |
0.00 |
(750.28%) |
547.89% |
— |
| FTH |
Faeth Therapeutics, Inc. |
750.66m |
28.00 |
(3.61%) |
0.00 |
0.00% |
— |
— |
| PHAR |
Pharming Group N.V. Sponsored ADR |
738.94m |
10.46 |
0.19% |
69.73 |
2.55% |
7.85% |
— |
| DBVT |
DBV Technologies S.A. |
734.72m |
11.56 |
(0.34%) |
0.00 |
(3,564.57%) |
27.12% |
— |
| ANNX |
Annexon, Inc. |
720.40m |
3.64 |
(4.21%) |
0.00 |
0.00% |
— |
— |
| NVCT |
Nuvectis Pharma, Inc. |
706.09m |
20.22 |
(6.52%) |
0.00 |
0.00% |
— |
— |
| OABI |
OmniAb, Inc. |
697.87m |
4.61 |
(3.76%) |
0.00 |
(115.12%) |
67.01% |
— |
| SLN |
Silence Therapeutics PLC Sponsored ADR |
697.32m |
11.18 |
(0.36%) |
0.00 |
0.00% |
(96.97%) |
— |
| VSTM |
Verastem, Inc. |
694.62m |
7.74 |
(0.38%) |
0.00 |
(231.59%) |
472.89% |
— |
| MDXG |
MiMedx Group, Inc |
686.53m |
4.67 |
(0.85%) |
116.75 |
1.76% |
(2.36%) |
— |
| DNA |
Ginkgo Bioworks Holdings, Inc. |
683.64m |
10.66 |
4.00% |
0.00 |
(219.60%) |
(37.02%) |
— |
| CLYM |
Climb Bio, Inc. |
682.92m |
11.66 |
(1.93%) |
0.00 |
0.00% |
— |
— |
| ZVRA |
Zevra Therapeutics, Inc. |
668.66m |
11.04 |
(1.95%) |
11.62 |
42.25% |
119.40% |
— |
| AURA |
Aura Biosciences, Inc. |
637.78m |
6.00 |
(2.44%) |
0.00 |
0.00% |
— |
— |
| STTK |
Shattuck Labs, Inc. |
633.29m |
6.07 |
(3.80%) |
0.00 |
0.00% |
106.48% |
— |
| NGNE |
Neurogene Inc. |
625.36m |
28.31 |
(9.54%) |
0.00 |
0.00% |
— |
— |
| PRME |
Prime Medicine, Inc. |
609.43m |
2.90 |
(5.54%) |
0.00 |
(4,613.11%) |
(17.90%) |
— |
| CRMD |
CorMedix Inc |
607.97m |
7.85 |
1.03% |
3.26 |
40.49% |
280.50% |
— |
| INDP |
Indaptus Therapeutics, Inc. |
606.77m |
3.85 |
(5.50%) |
0.00 |
0.00% |
— |
— |
| MNPR |
Monopar Therapeutics Inc. |
602.75m |
85.24 |
(4.05%) |
0.00 |
0.00% |
— |
— |
| CTMX |
CytomX Therapeutics, Inc. |
599.22m |
2.70 |
(1.82%) |
0.00 |
(451.62%) |
(87.03%) |
— |
| ALLO |
Allogene Therapeutics, Inc. |
594.24m |
1.65 |
(1.20%) |
0.00 |
(3,517.41%) |
7,613.11% |
— |
| ALT |
Altimmune, Inc. |
593.28m |
3.06 |
0.66% |
0.00 |
0.00% |
130.00% |
— |
| VALN |
Valneva SE Sponsored ADR |
589.78m |
6.14 |
(1.29%) |
65.32 |
(12.01%) |
(53.16%) |
— |
| ACRS |
Aclaris Therapeutics, Inc. |
588.97m |
5.15 |
(4.28%) |
0.00 |
(921.50%) |
(51.04%) |
— |
| MPLT |
MapLight Therapeutics, Inc. |
587.68m |
10.46 |
(2.79%) |
0.00 |
0.00% |
— |
— |
| OCS |
Oculis Holding AG |
579.54m |
9.27 |
(1.49%) |
0.00 |
(6,870.05%) |
65.83% |
— |
| PHAT |
Phathom Pharmaceuticals, Inc. |
572.78m |
7.30 |
4.58% |
0.00 |
(41.34%) |
110.16% |
— |
| SGMT |
Sagimet Biosciences Inc. |
561.10m |
9.24 |
1.43% |
0.00 |
0.00% |
— |
— |
| VECT |
VectivBio Holding AG |
545.50m |
— |
0.00% |
0.00 |
0.00% |
— |
— |
| EPRX |
Eupraxia Pharmaceuticals Inc. |
537.83m |
8.01 |
(1.84%) |
0.00 |
0.00% |
— |
— |
| CBIO |
Crescent Biopharma, Inc. |
528.93m |
13.99 |
(1.76%) |
0.00 |
0.00% |
(45.09%) |
— |
| DRUG |
Bright Minds Biosciences Inc. |
527.83m |
51.80 |
(1.78%) |
0.00 |
0.00% |
— |
— |